IP Library Granted Patent US 7,652,001
Granted Patent B2
US 7,652,001 · App. 11/053,198 · Granted Jan 26, 2010

Pharmacologically active agents containing esterified phosphonates and methods for use thereof

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,652,001
App. No.
11/053,198
Granted
Jan 26, 2010
Kind
B2
Abstract

Compounds and compositions are provided for treatment, prevention, or amelioration of a variety of medical disorders associated with viral infections, cell proliferation and bone metabolism. The compounds provided herein are alkyl esters of phosphonates.

Claims (8)

1. Eicosyl ester of cidofovir.

2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

3. A method for treating a viral infection in a mammal, wherein the method comprises administering to a subject in need thereof an effective amount of the compound of claim 1 .

4. The method of claim 3 , wherein the viral infection is caused by influenza, hepatitis B virus, hepatitis C virus, cytomegalovirus, Varicella zoster virus, Herpes simplex virus types 1 and 2, Epstein-Barr virus, Herpes type 6 and type 8, Varicella zoster virus, Epstein Barr virus infections, retroviral infections, orthopox viruses, vaccinia, ebola virus, adenovirus and papilloma virus.

5. The method of claim 3 , wherein the viral infection is an orthopox viral infection selected from the group consisting of smallpox, cowpox, camelpox, and monkeypox.

6. The method of claim 3 , wherein the viral infection is a herpes viral infection.

7. An article of manufacture, comprising packaging material and the compound of claim 1 , contained within the packaging material, wherein the compound is effective for treatment of a disease associated with a viral infection and the packaging material includes a label that indicates that the compound is used for treatment of a disease associated with a viral infection.

8. The method of claim 3 , wherein the viral infection is a hepatitis viral infection.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 23, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 027281/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2010
From: HOSTETLER, KARL Y.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; THE UNITED STATES OF AMERICA, DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 024562/0203 →
CONFIRMATORY LICENSE Recorded Oct 16, 2008
From: UNIVERSITY OF CALIFORNIA, SAN DIEGO
To: US GOVERNMENT - SECRETARY OF THE ARMY
Reel/Frame 021688/0512 →
Continuity (2)
Provisional Application 6054252200 · Feb 5, 2004
Related Publication 20050192246A1 · Sep 1, 2005